Bora Pharmaceuticals Co., LTD. (TPE:6472)
676.00
-12.00 (-1.74%)
Oct 7, 2025, 9:44 AM CST
TPE:6472 Market Cap
TPE:6472 has a market cap or net worth of 85.39 billion as of October 6, 2025. Its market cap has increased by 15.32% in one year.
Market Cap
85.39B
Enterprise Value
100.85B
Revenue
21.32B
Ranking
n/a
PE Ratio
18.19
Stock Price
676.00
Market Cap Chart
Since October 3, 2014, TPE:6472's market cap has increased from 3.16B to 85.39B, an increase of 2,600.75%. That is a compound annual growth rate of 34.91%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 3, 2025 | 85.39B | 9.89% |
Dec 31, 2024 | 77.71B | 20.27% |
Dec 29, 2023 | 64.61B | 107.61% |
Dec 30, 2022 | 31.12B | 150.04% |
Dec 30, 2021 | 12.45B | 17.05% |
Dec 31, 2020 | 10.63B | 89.60% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Caliway Biopharmaceuticals | 276.86B |
PharmaEssentia | 206.74B |
Lotus Pharmaceutical | 69.95B |
Lumosa Therapeutics | 49.53B |
Oneness Biotech | 31.18B |
Polaris Group | 27.66B |
Center Laboratories | 26.65B |
Pegavision | 24.73B |